Here's my weekly analysis of cases, deaths, vaccinations and restrictions.
At the global level, Omicron has driven an amazing surge in the last 2 weeks.
I've added a % Positive chart - this helps to spot when testing is overwhelmed (so infections are likely under-reported).
🧵
Australia is one of the worst affected countries (on a population basis). Restrictions were dropped in mid-December, ignoring the risk from multiple Omicron super-spreader events.
Testing has effectively collapsed - % Positive has soared to 31%, many infections are undiscovered.
In Denmark, both the cases and % positive appear to have peaked.
Deaths are at ~100 per week or ~170 per 10M. But as they typically lag cases by 3 weeks, we can expect them to increase, sadly.
France has seen cases soar in recent weeks to one of the highest rates globally for any large country - ~2,700 cases per 100K people.
Sadly deaths are beginning to rise also.
With relatively low vaccination rates and delayed 3rd dose rollout, the Netherlands has had to rely on restrictions and a lockdown.
These have been quite effective so far, keeping their case rates ~1,000 per 100K or less, but the recent trend is upwards.
In the UK, the curve of cases is showing signs of peaking, and the % Positive is relatively low.
3rd dose rates have closed the gap with the waning effect.
The situation in the US looks disastrous - a very high death rate probably resulting from the low vaccination rates.
The % Positive rate is up to almost 50%, so many infections are unreported.
3rd doses lag the waning effect by a wide margin, and over 25% remain unvaccinated.
Argentina seems the worst-affected country in South America. While the case rate does not look extreme at first glance, not the the % Positive is now over 60%
Singapore recently beat back a serious Delta wave, and while Omicron is spreading the case rates are relatively low so far.
Vaccination rates are impressive.
Japan successfully suppressed their Delta wave around the Olympics and have enjoyed very low case rates for several months.
An Omicron wave has started to build in the latest week, despite tight border restrictions.
Here’s the July 2025 update I just sent to my GitHub Sponsors.
I continued to share results from these projects, here and on other social media platforms
🧵
If you are in a position to support my open-source project work, then any amount is welcome. You just need to create a free GitHub account, and you can remain anonymous if you prefer.
There’s info on that page about how your contribution will be used.
This perspective excludes all the high-volume countries and regions that I routinely report on: Australia, NZ, Europe, Canada and the US. The remaining countries are aggregated into this report.
🧵
Here are the leading countries reporting the NB.1.8.1 "Nimbus" variant.
🧵
Here's the latest variant picture for the United States, to early July.
The XFG.* "Stratus" variant continued it’s dominance, growing to 58% frequency.
NB.1.8.1 "Nimbus" was fairly flat, finishing at 14%.
#COVID19 #USA #XFG #Stratus #NB_1_8_1 #Nimbus
🧵
Here are the leading US states reporting XFG.* "Stratus". New York state reported strong growth to 78%.
🧵
Here are the leading US states reporting NB.1.8.1 "Nimbus". Besides the International Traveller samples, it has been most common in California and Colorado, although all are roughly flat or declining lately.
🧵
The volatility is due to the ragged timing of submissions from various countries.
This perspective excludes all the high-volume countries and regions that I routinely report on: Australia, NZ, Europe, Canada and the US. The remaining countries are aggregated into this report.
🧵
Here are the leading countries reporting the NB.1.8.1 "Nimbus" variant.
🧵
Here's the latest variant picture for the United States, to late June.
The XFG.* "Stratus" variant grew to dominant at 40%, with LP.8.1.* at 28%.
Growth of the NB.1.8.1 "Nimbus" variant is slower, at 16%.
#COVID19 #USA #XFG #Stratus #NB_1_8_1 #Nimbus
🧵
For the US, the XFG.* "Stratus" variant shows a strong growth advantage of 5% per day (35% per week) over LP.8.1.*, with a crossover in mid-June.
🧵
Here are the leading US states reporting XFG.* "Stratus". New York state leads at 59%. It has also been quite common among the International Traveller samples at 46%.
🧵
Here are the trends across all the International Traveller samples. From that perspective, XFG.* "Stratus" is dominant at 48%.
This dataset (mostly arrivals in the US and Japan) is arguably more random, as it is not skewed by sequencing volumes.
🧵
Globally, the NB.1.8.1 "Nimbus" variant is showing a steady growth advantage of 3.1% per day (22% per week) over the LP.8.1.* variant, with a crossover in late May.
🧵